EV/EBITDA
-20.93
+0.55+2.56%
Fri, 07 Mar 2025 23:20:12 GMT
Summary
- As of March 9, 2025, MNPR EV/EBITDA is -20.93, with a rise of +0.55 (+2.56%) during the most recent trading day.
- Over the past year, MNPR EV/EBITDA has dropped by -20.21 (-2806.94%).
- MNPR EV/EBITDA is now -7076.67% below its all-time high of 0.30.
Performance
MNPR EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
MNPR EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +2.6% | -2.6% | -2.5% |
| 1 m1 month | +42.9% | -42.9% | -41.9% |
| 3 m3 months | -36.4% | +36.4% | +34.4% |
| 6 m6 months | -6651.6% | +6287.0% | +1109.2% |
| ytdytd | -33.1% | +33.1% | +31.4% |
| 1 y1 year | -2806.9% | +2204.8% | +532.4% |
| 5 y5 years | -8.1% | +74.9% | -36.9% |
MNPR EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | -38.58 | +45.8% | |
| 3 m | 3-month | -15.35 | -36.4% | -38.58 | +45.8% |
| 6 m | 6-month | -0.31 | -6651.6% | -38.58 | +45.8% |
| 1 y | 1-year | -0.22 | -9413.6% | -38.58 | +45.8% |
| 3 y | 3-year | 0.30 | -7076.7% | -38.58 | +45.8% |
| 5 y | 5-year | 0.30 | -7076.7% | -38.58 | +45.8% |
| alltime | all time | 0.30 | -7076.7% | -68.78 | +69.6% |
Monopar Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -20.93(+33.1%) |
| 2024 | -15.73(-6392.0%) |
| 2023 | 0.25(-111.7%) |
| Date | Value |
|---|---|
| 2022 | -2.14(-3.2%) |
| 2021 | -2.21(-73.0%) |
| 2020 | -8.20(-78.2%) |
| 2019 | -37.59 |
FAQ
- What is Monopar Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Monopar Therapeutics?
- What is MNPR EV/EBITDA year-to-date change?
- What is Monopar Therapeutics EV/EBITDA year-on-year change?
What is Monopar Therapeutics EV/EBITDA?
The current EV/EBITDA of MNPR is -20.93
What is the all time high EV/EBITDA for Monopar Therapeutics?
Monopar Therapeutics all-time high EV/EBITDA is 0.30
What is MNPR EV/EBITDA year-to-date change?
Monopar Therapeutics EV/EBITDA has changed by -5.20 (-33.06%) since the beginning of the year
What is Monopar Therapeutics EV/EBITDA year-on-year change?
Over the past year, MNPR EV/EBITDA has changed by -20.21 (-2806.94%)